Program
| 07:50 | Welcome John Granton & Marc de Perrot |
| CTEPH: AN OVERVIEW Chair: John Granton |
|
| 0800 | Prevalence and natural history of CTEPH Marc Humbert |
| 0830 | Risk factors for CTEPH Jakov Moric |
| 0900 | Impact of surgery on CTEPH Marc de Perrot |
| 0930 | When do I consider medical therapy in CTEPH? Richard Channick |
| 1000 | Panel discussion |
| 1015 | Coffee break |
| CTEPH: EVIDENCE AND GUIDELINES Chair: Marc de Perrot |
|
| 1045 | Canadian guidelines for CTEPH: an evidence based review Sanjay Mehta |
| 1115 | Management of massive pulmonary emboli John Granton |
| 1145 | Anticoagulation for VTE: for how long and what kind ? Clive Kearon |
| 1215 | Panel discussion |
| 1230 | Lunch |
|
CTEPH AND SMALL PULMONARY VESSELS |
|
| 1330 | Pathobiology of CTEPH Marc Humbert |
| 1400 | CTA and MRI: what is best for CTEPH? Heidi Roberts |
| 1430 | Case presentation John Thenganatt |
| 1445 | Panel discussion |
| 1500 | Coffee break |
| CHRONIC THROMBOEMBOLIC DISEASE AND EXCERCISE INDUCED PH Chair: John Granton |
|
| 1530 | Exercise induced PH: what investigations should I do? Steeve Provencher |
| 1600 | Management of chronic embolic disease without PH Richard Channick |
| 1630 | Case presentation Isabelle Opitz |
| 1645 | Panel discussion |
| 1700 | Adjourn |
